We also found that PVT1/miR-619-5p could target ATG14 and promote cellular autophagic activity, and pharmacological or genetic inhibition of autophagy activity restored pancreatic cancer gemcitabine sensitivity. The gene discussed is PVT1; the disease is familial pancreatic carcinoma.